New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study

Abstract Background In patients with diffuse large B-cell lymphoma (DLBCL), central nervous system (CNS) relapse is uncommon but is nearly always fatal. This study aimed to determine the risk factors for CNS relapse in DLBCL patients and to evaluate the efficacy of rituximab and intrathecal chemothe...

Full description

Bibliographic Details
Main Authors: Qing-Qing Cai, Li-Yang Hu, Qi-Rong Geng, Jie Chen, Zhen-Hai Lu, Hui-Lan Rao, Qing Liu, Wen-Qi Jiang, Hui-Qiang Huang, Tong-Yu Lin, Zhong-Jun Xia
Format: Article
Language:English
Published: BMC 2016-09-01
Series:Chinese Journal of Cancer
Subjects:
Diffuse large B-cell lymphoma
Central nervous system relapse
Risk factor
Rituximab
Intrathecal chemotherapy prophylaxis
Online Access:http://link.springer.com/article/10.1186/s40880-016-0150-y

Internet

http://link.springer.com/article/10.1186/s40880-016-0150-y

Similar Items